Director, Value Outcomes Liaison (VOL)

The Director, Value Outcomes Liaison will engage US population‑based decision makers such as payers, health systems, and policy makers to communicate clinical, economic, and humanistic data on ivonescimab. The role supports formulary access and pathway decisions through scientific engagement, evidence presentation, and collaboration with internal market access and medical affairs teams.